# Cameco Corp: financial statements, quarterly

CCJ · NYSE · CIK 1009001 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ccj.md) · [Financials](/companies/ccj/financials.md) · [Filings](/companies/ccj/filings.md) · [Insiders](/companies/ccj/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ccj/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2015-12-31) | period not labelled (2016-12-31) | FY2017 (2017-12-31) | FY2018 (2018-12-31) | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.5](/filings/0001193125-18-099445.md) | [0.3](/filings/0001193125-19-092356.md) | [0.6](/filings/0001193125-20-088317.md) | [0.7](/filings/0001193125-21-087174.md) | [1.1](/filings/0001193125-22-081448.md) | [0.9](/filings/0001193125-23-083565.md) | [1.2](/filings/0001193125-24-075464.md) | [1.1](/filings/0001193125-25-060350.md) | [0.6](/filings/0001193125-26-116229.md) | [0.6](/filings/0001193125-26-116229.md) | [1.1](/filings/0001193125-26-116229.md) |
| Current assets | $bn | not reported | [2.0](/filings/0001193125-18-099445.md) | [2.1](/filings/0001193125-19-092356.md) | [2.1](/filings/0001193125-20-088317.md) | [1.8](/filings/0001193125-21-087174.md) | [1.9](/filings/0001193125-22-081448.md) | [2.1](/filings/0001193125-23-083565.md) | [3.3](/filings/0001193125-24-075464.md) | [1.8](/filings/0001193125-25-060350.md) | [1.9](/filings/0001193125-26-116229.md) | [2.6](/filings/0001193125-26-116229.md) |
| Total assets | $bn | not reported | [8.2](/filings/0001193125-18-099445.md) | [7.8](/filings/0001193125-19-092356.md) | [8.0](/filings/0001193125-20-088317.md) | [7.4](/filings/0001193125-21-087174.md) | [7.6](/filings/0001193125-22-081448.md) | [7.5](/filings/0001193125-23-083565.md) | [8.6](/filings/0001193125-24-075464.md) | [9.9](/filings/0001193125-25-060350.md) | [9.9](/filings/0001193125-26-116229.md) | [10.3](/filings/0001193125-26-116229.md) |
| Current liabilities | $bn | not reported | [0.5](/filings/0001193125-18-099445.md) | [0.4](/filings/0001193125-19-092356.md) | [0.9](/filings/0001193125-20-088317.md) | [0.3](/filings/0001193125-21-087174.md) | [0.3](/filings/0001193125-22-081448.md) | [0.4](/filings/0001193125-23-083565.md) | [0.6](/filings/0001193125-24-075464.md) | [1.2](/filings/0001193125-25-060350.md) | [1.2](/filings/0001193125-26-116229.md) | [1.1](/filings/0001193125-26-116229.md) |
| Shareholders' equity | $bn | [5.5](/filings/0001193125-18-099445.md) | [5.3](/filings/0001193125-18-099445.md) | [4.9](/filings/0001193125-19-092356.md) | [5.0](/filings/0001193125-20-088317.md) | [5.0](/filings/0001193125-21-087174.md) | [5.0](/filings/0001193125-22-081448.md) | [4.8](/filings/0001193125-23-083565.md) | [5.8](/filings/0001193125-24-075464.md) | [6.1](/filings/0001193125-25-060350.md) | [6.4](/filings/0001193125-26-116229.md) | [6.9](/filings/0001193125-26-116229.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Current assets: ifrs-full:CurrentAssets
- Total assets: ifrs-full:Assets
- Current liabilities: ifrs-full:CurrentLiabilities
- Shareholders' equity: ifrs-full:Equity, ifrs-full:EquityAttributableToOwnersOfParent

Shares outstanding: 435,457,978 at 2025-12-31, from the cover of the [40-F filed 2026-03-19](/filings/0001193125-26-116229.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:30 ET. No prices; not investment advice.